Vanguard Fiduciary Trust’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
Vanguard Fiduciary Trust's HCAT Position: Q2 2026 in Review
Vanguard Fiduciary Trust increased its Health Catalyst (HCAT) stake by 4.4% in Q2 2026, buying an estimated $27.9K and bringing the position to 463,005 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #3058.
Vanguard Fiduciary Trust first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- Vanguard Fiduciary Trust held 463,005 shares of Health Catalyst worth $921K as of Q2 2026.
- Vanguard Fiduciary Trust bought 19,340 Health Catalyst shares in Q2 2026, an estimated $27.9K.
- Health Catalyst made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3058 holding.
- Vanguard Fiduciary Trust first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
- 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.